Cell-culture system for continuous production of Toxoplasma gondii tachyzoites

被引:40
作者
Evans, R [1 ]
Chatterton, JMW [1 ]
Ashburn, D [1 ]
Joss, AWL [1 ]
Ho-Yen, DO [1 ]
机构
[1] Raigmore Hosp, Highland Acute Hosp NHS Trust, Scottish Toxoplasma Reference Lab, Dept Microbiol, Inverness IV2 3UJ, Scotland
关键词
D O I
10.1007/s100960050423
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to identify a sustainable cell line and culture method that could continuously provide a sufficient quantity of Toxoplasma gondii tachyzoites to serve the needs of a general hospital laboratory. Three continuous cell lines (HeLa, LLC and Vero) and three cell-culture methods (culture in conventional flasks, culture in membrane-based flasks and an automated culture system) were investigated. In multiplicity of-infection and time-course experiments, HeLa was the cell line of choice. Harvests from HeLa cells had significantly higher tachyzoite yields than those from LLC cells (P < 0.00005) or Vero cells (P < 0.05). Membrane-based flasks gave higher yields (6.15 x 10(6) tachyzoites/ml) than conventional flasks (1-2 x 10(6) tachyzoites/ml) initially, but these were not sustained. The automated cell-culture system was unsuitable for parasite culture. Continuous passage in 25 cm(2) flasks was successful, yielding 1 x 10(6) tachyzoites/ml; viability exceeded 90% after 96-120 h of infection throughout 38 passes, during which time the viability improved and the time to harvest became more consistent. Toxoplasma gondii grown in continuous culture in HeLa cells can provide a regular supply of viable tachyzoites. Demonstration that HeLa-derived tachyzoites could be used for the dye test confirms the potential of this in vitro system for use in general hospital laboratories.
引用
收藏
页码:879 / 884
页数:6
相关论文
共 20 条
[1]   Do IgA, IgE, and IgG avidity tests have any value in the diagnosis of toxoplasma infection in pregnancy? [J].
Ashburn, D ;
Joss, AWL ;
Pennington, TH ;
Ho-Yen, DO .
JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (04) :312-315
[2]  
BRAVENY I, 1978, TROPENMED PARASITOL, V29, P432
[3]  
BUCKLEY SM, 1973, EXP PARASITOL, V33, P23, DOI 10.1016/0014-4894(73)90005-2
[4]   CALIBRATION OF AN IN-VITRO ASSAY SYSTEM USING A NONADHERENT CELL-LINE TO EVALUATE THE EFFECT OF A DRUG ON TOXOPLASMA-GONDII [J].
BUNETEL, L ;
GUERIN, J ;
ANDRE, P ;
ROBERT, R ;
DEUNFF, J .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1995, 25 (06) :699-704
[5]   ISOLATION OF TOXOPLASMA-GONDII FROM IMMUNOCOMPROMISED PATIENTS USING TISSUE-CULTURE [J].
CALICO, I ;
CABALLERO, E ;
MARTINEZ, O ;
ARCE, LA ;
LLOPART, L ;
OCANA, I ;
JUSTE, C .
INFECTION, 1991, 19 (05) :340-342
[6]   COMPARATIVE-STUDY OF TISSUE-CULTURE AND MOUSE INOCULATION METHODS FOR DEMONSTRATION OF TOXOPLASMA-GONDII [J].
DEROUIN, F ;
MAZERON, MC ;
GARIN, YJF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (09) :1597-1600
[7]   A METHOD TO OBTAIN LARGE QUANTITIES OF TOXOPLASMA-GONDII TACHYZOITES WITH EXTREME PURITY [J].
DOMZIG, W ;
SEGUELA, JP ;
BINZ, H .
JOURNAL OF PARASITOLOGY, 1993, 79 (04) :613-615
[8]   A MICROMODIFICATION OF TOXOPLASMA DYE TEST [J].
FELDMAN, HA ;
LAMB, GA .
JOURNAL OF PARASITOLOGY, 1966, 52 (02) :415-&
[9]   IN-VITRO ASSAYS ELUCIDATE PECULIAR KINETICS OF CLINDAMYCIN ACTION AGAINST TOXOPLASMA-GONDII [J].
FICHERA, ME ;
BHOPALE, MK ;
ROOS, DS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1530-1537
[10]   A plastid organelle as a drug target in apicomplexan parasites [J].
Fichera, ME ;
Roos, DS .
NATURE, 1997, 390 (6658) :407-409